E.I. DuPont De Nemours & Co. v. Faupel

859 A.2d 1042, 2004 WL 249569, 2004 Del. Super. LEXIS 19
CourtSuperior Court of Delaware
DecidedJanuary 30, 2004
DocketC.A. 03A-04-014-RRC
StatusPublished
Cited by4 cases

This text of 859 A.2d 1042 (E.I. DuPont De Nemours & Co. v. Faupel) is published on Counsel Stack Legal Research, covering Superior Court of Delaware primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
E.I. DuPont De Nemours & Co. v. Faupel, 859 A.2d 1042, 2004 WL 249569, 2004 Del. Super. LEXIS 19 (Del. Ct. App. 2004).

Opinion

OPINION

COOCH, J.

I. INTRODUCTION

This is an appeal of a decision of the Industrial Accident Board (“LAB”) holding that Barbara Faupel’s (“Faupel”) injury, Guillain-Barré Syndrome/chronic inflammatory demyelinating polyneuropathy, which resulted from an influenza vaccination administered to her by her employer E.I. duPont De Nemours & Co. (“DuPont”), was within the course and scope of her employment and therefore compensa-ble under the Workers’ Compensation Act. This Court finds that there was substantial evidence to support the IAB’s decision and affirms the decision of the Board. This Court holds that a flu vaccination, resulting in injury, “may be covered [by the Workers’ Compensation Act] if there is a combination of strong urging by the employer and some element of mutual benefit in the form of lessened absenteeism and improved employee relations.” 1 This is an issue of apparent first impression in Delaware.

II. FACTUAL AND PROCEDURAL HISTORY

Faupel was employed by DuPont from March 1970 until October 29, 2001. 2 In *1045 2000, Faupel was promoted to an “executive” level position and moved to DuPont’s offices in the “Hotel DuPont”. 3 In 1976, Faupel had received the Swine Flu vaccination, which was administered at work by DuPont, and she became ill after receiving the vaccination. 4 Faupel declined to receive any flu vaccinations between 1977 and 2001. 5 Faupel testified that she decided to receive the flu vaccination in October 2001 because she felt that in her new position she needed to be “on the job” for her boss. 6 She also stated that her family doctor suggested that she get a flu vaccination because of her age and because she was also caring for elderly parents. 7 Fau-pel received a flu vaccination, administered by DuPont, on October 18, 2001. 8

DuPont’s medical health department, where Faupel received her vaccination, has provided occupational health services to employees and a limited array of nonoccupational medical services. 9 DuPont has offered flu vaccinations every year to employees who wish to receive the vaccination. 10 There were no incentives or requirements that employees receive the vaccination and the program was provided as a convenience to employees. 11

DuPont informed employees about the vaccination program through flyers and bulk e-mail messages. 12 Faupel testified that there were posters announcing the vaccination program posted at eye level by the restrooms, in the photocopier room, in her department, by the elevators and going “in and out of the work area.” 13 Some of the posters, she testified, encouraged people to get the flu shot “while supplies last.” 14 One e-mail read,

FLU SHOT SCHEDULE!!!!
Flu shots will be given at the Chestnut Run Medical Clinic located in Bldg. 700 on the following days and times:
Friday, October 26, 9:00am to 11:00 am, and 1:80pm to 8:00pm
Monday, October 29, 9:00am to 11:00am and 1:30pm to 3:00pm.
Future flu shot dates will be announced based on our supply of vaccine. 15

Employees in Faupel’s department were scheduled to get their vaccinations on October 24; however, Faupel testified that on October 18, Clava Queenan, the secretary from the DuPont medical department, offered her the opportunity to receive the *1046 vaccination early because Faupel was working with “upper management.” 16

Everett C. Sparks, R.N., a DuPont employee, administered the vaccination to Faupel during regular work hours in the DuPont building. 17 Sparks testified that a vaccination is a preventative measure, it can reduce absenteeism at work and in addition to being a preventative measure, he testified that employer provided vaccinations promote good employee relations. 18 Sparks stated that when an employee gets the flu, he or she could be out of work for up to two weeks. 19

Faupel began to feel ill about a week after receiving the vaccination. 20 Faupel initially sought medical treatment from DuPont’s medical health department but was eventually referred to her family doctor. 21 Faupel went to the hospital because of the continuing deterioration of her condition, which included numbness and partial paralysis in her lower extremities; eventually, Faupel suffered complete paralysis from the waist down. 22 After several months of rehabilitation, Faupel regained the use of her legs; however as of the date of the IAB hearing, she continued to have no feeling in her legs and used crutches or a motorized scooter to get around. 23 Faupel was diagnosed with Guillian-Barré Syndrome/chronic inflammatory demyelinating polyneuropathy (“CIDP”). 24

Faupel filed a petition with the IAB in November 2002 to determine compensation due alleging that her condition was the result of the vaccination she received at work. She sought compensation for ongoing total disability and payment of related medical expenses. DuPont disputed whether Faupel’s CIDP resulted from the vaccine and whether it provided the vaccination within the course and scope of her employment. 25

III. STANDARD OF REVIEW

The Supreme Court and this Court have repeatedly emphasized the limited appellate review of the factual findings of an administrative agency. The function of the reviewing Court is to determine whether the agency’s decision is supported by substantial evidence. 26 Substantial evidence means such relevant evidence as a reasonable mind might accept as adequate to support a conclusion. 27

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Burroughs v. Kent County Assessment Office
Superior Court of Delaware, 2025
Rolsen v. Walgreen Co.
2016 Ohio 8304 (Ohio Court of Appeals, 2016)
Robert LaRue v. Evraz Claymont Steel
Superior Court of Delaware, 2016

Cite This Page — Counsel Stack

Bluebook (online)
859 A.2d 1042, 2004 WL 249569, 2004 Del. Super. LEXIS 19, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ei-dupont-de-nemours-co-v-faupel-delsuperct-2004.